| |
|
Form Serial Number: |
IS20180619E00350
|
| 1.
Date of relevant event: |
13/06/2018
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01548 |
| 4.
Name of listed corporation: |
Genscript Biotech Corporation |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
1,833,285,795 |
| 7.
Name of substantial shareholder (English) as printed on HKID Card/Passport: |
| (Surname) |
HU |
| (Other names) |
ZHIYONG |
|
|
|
| 10.
Name of substantial shareholder (Chinese): |
胡智勇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 14.
Details of relevant event: |
| |
Brief description of relevant event |
Capacity in which shares were/are held |
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange |
Off Exchange |
| Before relevant event |
After relevant event |
Highest price (per share) |
Average price (per share) |
Average consideration (per share) |
Nature of consideration |
| Long position |
| 1111 | The percentage level of your interest in the shares has increased because:
new shares were issued to you after you have reduced your interest in shares by placing them to placee(s) under a top-up placing |
|
|
|
75,000,000 |
HKD |
|
|
26.5000 |
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 15.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 995,955,561 | 54.32 |
|
| |
| 16.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 995,955,561 | 54.32 |
|
| |
| 17.
Capacity in which interests disclosed in Box 16 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2401 | A concert party to an agreement to buy shares described in s.317(1)(a) |
| |
| |
|
| |
| 18.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
| |
| 19.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Wang Ye | |
|
| |
| 20.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling shareholder | % control | Direct interest (Y/N) | Number of shares |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Zhang Fangliang | 28.83 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Luquan | 23.68 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Ye | 6.02 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Zhang Fangliang | 12.04 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Ye | 6.02 | Y | |
|
| |
| 21.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 22.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| 2017 WANG YE FAMILY TRUST | Addresses of individuals are not displayed. | | |
|
| |
| 23.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
| |
| 24.
Supplementary information: |
As disclosed in the announcement of Genscript Biotech Corporation (the "Company") dated 5 June 2018, 8 June 2018 and 13 June 2018, a shareholder entered into the placing and subscription agreement dated 5 June 2018, pursuant to which the Company allotted and issued to such shareholder an aggregate of 75,000,000 ordinary shares of the Company.
|
| 25.
Log/Serial Number of the previous form: |
|
| 26.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 1: |
19/06/2018
(dd/mm/yyyy)
|
| |